RHRama Burhan Hasan

Rama Burhan Hasan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rama Burhan Hasan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gas chromatography–mass spectrometry analysis and comprehensive evaluation of antibacterial, antioxidant and anti‐inflammatory properties of T hymus capitatus extracts from L ibya

    by Ahmed Saeed Kabbashi, Taher Issa Shailabi, Ahlam Mohamed Keshar, Amel Mahmoud Abdrabo, Ahmed Ali Mustafa, Bushray Salih Jabullah, Rama Burhan Hasan, Mona Rafea Mosa, Esraa Radwan Ibrahim, Maryam Mohammed Ibrahim

    Background: The emergence of multidrug‐resistant bacteria necessitates the development of alternative therapeutic approaches. Thymus capitatus , a Mediterranean medicinal plant, has been traditionally used to treat various ailments, but its bioactive potential from Libyan origins remains underexplored. Results: The ethanol extract demonstrated superior bioactivity, significantly inhibiting S. aureus (37.3 ± 2.51 mm) and P. vulgaris (20.3 ± 0.75 mm). GC–MS analysis revealed 18 compounds, with thymol (35.07%) as the major constituent. The ethanolic extract showed potent bactericidal activity against S. aureus (MIC = 62.5 μg/mL, MBC = 125 μg/mL, MBC/MIC = 2). Both extracts exhibited concentration‐dependent anti‐inflammatory activity, with IC 50 values of 244.51 μg/mL (ethanolic) and 251.33 μg/mL (aqueous). The ethanolic extract showed substantial antioxidant potential (IC 50 = 189.4 ± 0.01 μg/mL), whereas both extracts were non‐toxic (LD 50 > 1000 μg/mL). Conclusion: These in vitro findings suggest that T. capitatus extracts possess significant therapeutic potential, supporting their traditional use. GC–MS confirmed thymol as the principal bioactive marker. However, further in vivo studies are necessary to validate these findings.

  • Open Access

    Comprehensive Phytochemical Profiling and Multi‐Target Biological Evaluation of Hibiscus sabdariffa L. Calyx Extracts From Libya: A Promising Functional Food Candidate With Antibacterial, Antioxidant, Anti‐Inflammatory, and Cytotoxic Properties: Validation Through In Silico Approaches

    by Ahmed Saeed Kabbashi, Zuhir S. Mussa Akrim, Mohammed B. Suliman, Sanadelaslam S. A. El‐Hddad, Ahmed Ali Mustafa, Maryam Mohammed Ibrahim, Esraa Radwan Ibrahim, Mona Rafea Mosa, Rama Burhan Hasan

    The global escalation of antimicrobial resistance necessitates the exploration of plant‐based therapeutics with multi‐target mechanisms. This study provides a comprehensive evaluation of the Libyan Hibiscus sabdariffa L. calyx extract, encompassing phytochemical characterization, in vitro bioactivity, and in silico validation. Aqueous and ethanolic extracts were prepared and screened for antibacterial activity against clinically relevant multidrug‐resistant isolates (including determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)), antioxidant capacity via the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) radical assay, anti‐inflammatory effects by measuring their inhibition of albumin denaturation, and cytotoxicity using the brine shrimp lethality model. Gas Chromatography–Mass Spectrometry (GC–MS) analysis of the ethanolic extract revealed that the predominant fatty acid esters were oleic acid methyl ester (41.01%) and palmitic acid methyl ester (28.76%). Both extracts exhibited broad‐spectrum antibacterial activity, with MIC values ranging from 6.25 to 25 mg/mL and MBC/MIC ratios ≤ 2, confirming their bactericidal activity. The aqueous and ethanolic extracts showed superior efficacy against Pseudomonas aeruginosa (20.0 ± 1.73 mm inhibition zone; MIC: 6.25 mg/mL) and Staphylococcus aureus (20.0 ± 1.00 mm; MIC: 6.25 mg/mL), respectively. The antioxidant activities were comparable (IC 50 : 283.6 vs. 292.1 μg/mL). Remarkably, the aqueous extract demonstrated potent anti‐inflammatory activity (IC 50 : 129.81 μg/mL) and showed low preliminary toxicity in the brine shrimp lethality assay (LD 50 > 1000 μg/mL), whereas the ethanolic extract exhibited moderate toxicity (LD 50 : 345.5 μg/mL). Preliminary phytochemical screening of the aqueous extract revealed the presence of anthocyanins, flavonoids, tannins, phenolics, saponins, and reducing sugars, with a total phenolic content of 184.3 ± 5.2 mg GAE/g and a total flavonoid content of 92.7 ± 3.8 mg QE/g. Molecular docking showed that the identified compounds, such as linoleic acid methyl ester, exhibited strong binding affinities to bacterial DNA gyrase (up to −5.9 kcal/mol) and inflammatory targets, including COX‐2, 5‐LOX, and TNF‐α. ADMET predictions indicated favorable pharmacokinetic profiles for these compounds. These findings scientifically validate the traditional use of H. sabdariffa and highlight the potential of its aqueous extract as a promising source of bioactive compounds warranting further preclinical investigation for functional food and complementary health applications.